Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thrombotic Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06355258
What this trial is testing

The Efficacy of Troxerutin in Preventing Thrombotic Events in COVID-19 Patients

Who this might be right for
COVID 19 Associated Coagulopathy
Westlake University 80
Early research (Phase 1)Looking for participantsNCT04323748
What this trial is testing

Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura

Who this might be right for
Immune Thrombocytopenic Purpura
New York Medical College 20
Not applicableLooking for participantsNCT05646394
What this trial is testing

Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS

Who this might be right for
Antiphospholipid SyndromeArterial Thrombosis
McMaster University 150
Not applicableNot Yet RecruitingNCT07429942
What this trial is testing

Learn More About the Treatment of People With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Who Received Recombinant ADAMTS13 (rADAMTS13) as Part of the Early Access Program

Who this might be right for
Thrombotic Thrombocytopenic Purpura (TTP)
Takeda 94
Not applicableStudy completedNCT06919731
What this trial is testing

PLATELET TISSUE FACTOR AS BIOMARKER OF THROMBOTIC RISK IN CORONARY ARTERY DISEASE PATIENTS (TRIT-ONE)

Who this might be right for
Cardiovascular Diseases
Centro Cardiologico Monzino 600
Testing effectiveness (Phase 2)Study completedNCT02222545
What this trial is testing

Safety and Efficacy Study of OMS721 in Patients With Thrombotic Microangiopathies

Who this might be right for
Thrombotic Microangiopathies
Omeros Corporation 58
Not applicableNot Yet RecruitingNCT06873672
What this trial is testing

Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China

Who this might be right for
Quality of Life (QOL)Patient-Reported Outcome Measures (PROMs)Pneumonia Childhood+3 more
RenJi Hospital 360
Not applicableStudy completedNCT03795883
What this trial is testing

The Thrombotic Potential of Heart Chambers in the Presence or Absence of Atrial Fibrillation.

Who this might be right for
Atrial FibrillationThrombosis CardiacLeft Atrial Thrombosis
Rambam Health Care Campus 47
Not applicableUnknownNCT06285435
What this trial is testing

Coagulation Activation in Patients With Pemphigus

Who this might be right for
Pemphigus
Assiut University 54
Large-scale testing (Phase 3)Study completedNCT00116688
What this trial is testing

Open Label Extension Study of Romiplostim (AMG 531) in Thrombocytopenic Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Who this might be right for
ThrombocytopeniaIdiopathic Thrombocytopenic Purpura
Amgen 313
Not applicableStudy completedNCT03280641
What this trial is testing

D-dimer In Patients With atRial Fibrillation rEceiving antiCoagulation Therapy

Who this might be right for
Atrial FibrillationStrokes Thrombotic
Wuhan Asia Heart Hospital 1,194
Testing effectiveness (Phase 2)Study completedNCT04278924
What this trial is testing

TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
Takeda 41
Not applicableAvailableNCT02355782
What this trial is testing

OMS721 Compassionate Use in Patients With Thrombotic Microangiopathy

Who this might be right for
Thrombotic Microangiopathy
Michal Nowicki
Large-scale testing (Phase 3)Study completedNCT04188379
What this trial is testing

Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

Who this might be right for
Primary Immune Thrombocytopenia
argenx 131
Large-scale testing (Phase 3)Looking for participantsNCT06389474
What this trial is testing

Efficacy of INM004 in Children With STEC-HUS

Who this might be right for
Hemolytic-Uremic Syndrome
Inmunova S.A. 220
Not applicableNot Yet RecruitingNCT07059910
What this trial is testing

Prevalence of Thyroid Disorders in Patients With Immune Thrombocytopenic Purpura and Its Impact on Treatment

Who this might be right for
Immune Thrombocytopenic PurpuraThyroid Disorders
Assiut University 100
Not applicableEnded earlyNCT01522170
What this trial is testing

AHUS Observational Long Term Follow-Up

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Alexion Pharmaceuticals, Inc. 94
Not applicableStudy completedNCT06451484
What this trial is testing

Grade Analysis of Veins by MRI and CT in Post-Thrombotic Syndrome

Who this might be right for
Lower Limb Venous Thrombosis
University Hospital, Bordeaux 50
Not applicableUnknownNCT04113915
What this trial is testing

Viral Hepatitis B and C Infection in Patients With Idiopathic Thrombocytopenic Purpura Treated With Triple Therapy

Who this might be right for
ITP - Immune Thrombocytopenic PurpuraViral Hepatitis
Safaa AA Khaled 150
Large-scale testing (Phase 3)Study completedNCT03222843
What this trial is testing

Multicentre, Randomised Phase III Study of the Efficacy and Safety of Hetrombopag Olamine in Idiopathic Thrombocytopenic Purpura (ITP) Patient

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Jiangsu HengRui Medicine Co., Ltd. 424
Next Page